Only 2.35% of total expenditure on health in Brazil is with medical devices (DMAs), ie, only 9.67% of Gross Domestic Product (GDP) of the segment in 2014. The percentage lags behind European countries less economic scale like Belgium (4.61%) and Greece (3.23%). Countries that invest in DMAs in the world are Germany (6.49%), followed by Japan (6.13%) and South Korea (5.73%).
The DMAs segment in Brazil covers almost 15,000 companies and about 4000 workers, with just over 10,000 professionals working in the marketing of medical products. With the addition of diagnostic and therapeutic services, this market generates around 225,000 indirect jobs.
The president of ABIIS, Carlos Eduardo Gouvea, among the many reasons for the low investment in medical devices is the difficult access to basic items for an increasingly effective and safe therapy for lack of incorporation in the system – by SUS or by Operators of Health- or even unaware of its importance. To Gouvea, an example is the case of some diagnostics that could act early in preventing certain diseases. “This lack of knowledge is not just the lay population, but often health professionals end up not following the evolution of innovation in the industry that is so dynamic,” he said in release.
It is estimated that the return on investment is large DMAs. “Being a very active segment in incremental innovation, where the research and development start from suggestions and ideas coming from the health professionals themselves, increasingly so it can be closer to the real market need. On the other hand, the professionals employed in the sector have to update permanently the technical and scientific point of view, raising the level of education of an entire group, “Gouêa concluded on release to the market.